CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 120 filers reported holding CHEMOCENTRYX INC in Q2 2019. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $41,328,000 | +21.3% | 800,000 | -14.5% | 0.23% | +34.7% |
| Q4 2021 | $34,060,000 | +416.0% | 935,463 | +142.3% | 0.17% | +448.4% |
| Q3 2021 | $6,601,000 | -88.9% | 386,000 | -74.3% | 0.03% | -92.2% |
| Q4 2019 | $59,325,000 | +334.6% | 1,500,000 | -25.5% | 0.40% | +288.3% |
| Q3 2019 | $13,651,000 | -26.6% | 2,013,396 | +0.7% | 0.10% | -14.9% |
| Q2 2019 | $18,600,000 | -10.7% | 2,000,000 | +33.3% | 0.12% | -22.9% |
| Q1 2019 | $20,835,000 | +31.7% | 1,500,000 | +3.4% | 0.16% | +35.3% |
| Q4 2018 | $15,820,000 | +8.8% | 1,450,000 | +26.1% | 0.12% | +34.9% |
| Q3 2018 | $14,536,000 | -4.0% | 1,150,000 | 0.0% | 0.09% | -8.5% |
| Q2 2018 | $15,146,000 | +17.2% | 1,150,000 | +21.1% | 0.09% | +5.6% |
| Q1 2018 | $12,920,000 | – | 950,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |